The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2024

Filed:

Jun. 13, 2021
Applicant:

Complete Omics Inc., Baltimore, MD (US);

Inventor:

Qing Wang, Owings Mills, MD (US);

Assignee:

COMPLETE OMICS INTERNATIONAL INC., Baltimore, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 30/06 (2006.01); G01N 1/28 (2006.01); G01N 1/34 (2006.01); G01N 1/40 (2006.01); G01N 30/72 (2006.01); G01N 30/88 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 30/06 (2013.01); G01N 1/286 (2013.01); G01N 1/34 (2013.01); G01N 1/405 (2013.01); G01N 30/7233 (2013.01); G01N 30/88 (2013.01); G01N 33/6848 (2013.01); G01N 2001/2866 (2013.01); G01N 2030/8804 (2013.01); G01N 2030/8831 (2013.01); G01N 2333/70539 (2013.01);
Abstract

A method for characterizing a target peptide through a detection approach such as mass spectrometry is provided, including: introducing at least one guard molecule to mix with the target peptide; and applying the detection approach for the characterization of the target peptide. Each guard molecule is configured to have similar characteristics as the target peptide, yet is still distinguishable therefrom by the detection approach, such as having a mass spectrometry-distinguishable different M/z value compared with the target peptide. The method can be used to characterize a neoantigen peptide through mass spectrometry, upstream of which the method can further include steps for tissue sample preparation, HLA molecules enrichment, elution, clean-up, and purification. Some or all of these steps can be configured to be executed in a substantially automatic manner with little or no manual intervention. A system for implementing the neoantigen analysis method is further provided.


Find Patent Forward Citations

Loading…